Építés alatt – nem éles oldal
Belépés
Fut, nem toborozFázis nélkül

HPV Self-testing in Transgender Individuals

A legfontosabb adatok

Ki végzi
Queen Mary University of London
Hol
Egyesült Királyság3 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Fut, nem toboroz
Résztvevők
100 fő, tervezett
Kezdés
2024. febr. 29.
Várható befejezés
2026. nov. 29.
A vizsgálat típusa
Beavatkozással járó, 2 csoport
A vizsgált kezelések
  • HPV DNA methylation assay
A regiszteradat frissítve
2026. február 19.

Ki vehet részt

Életkor
21 év – 65 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • Identify as transgender or non-binary
  • Be between 25 - 65 years of age
  • Be registered with a general practitioner
  • Have an intact cervix
  • Have used testosterone therapy within the last year
  • Be willing, and able to understand and consent to study procedures
  • Identify as transgender or non-binary
  • Be 18 years of age or older
  • Have undergone vaginoplasty by any method at least 1 year ago
  • Be willing, and able to understand and consent to study procedures

Ki nem vehet részt

  • Have a variation of sex characteristics (also known as a disorder of sex development)
  • Have an allergy to any of the ingredients in the oral rinse (Scope)
  • Be diagnosed with, or under investigation for, an inflammatory bowel disease (e.g., ulcerative colitis, Crohn's disease). This does not include irritable bowel syndrome - participants with this are eligible to enroll
  • Be a member of a vulnerable population, which includes pregnant people, fetuses, children, prisoners, or anyone unable to independently offer consent

Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Human papillomavirus (HPV) is a common virus that spreads through skin-to-skin contact. Some HPV types can cause changes in cells that lead to cancer and are known as 'high-risk' HPV (hrHPV). hrHPV is linked to cancers of the cervix (opening of the womb), throat, and anus (exit of the bowel).

A teljes eredeti leírásKevesebb

It is not known if transgender people (individuals whose gender identity does not align with their sex assigned at birth) are at increased risk of hrHPV or cancers caused by hrHPV compared to cisgender people (individuals whose gender identity does align with their birth sex). There is also little knowledge about HPV in the vagina for transgender women who have surgery to make one.

Transgender men may be at higher risk of cervical cancer than cisgender women because they are less likely to go for screening. This can be because of physical discomfort and emotional distress during screening when a swab is taken directly from the cervix.

The investigators seek to examine how common hrHPV is in transgender people in different parts of the body. In the study, participants will take swabs from the vagina and anus, a urine sample, and use mouthwash. Transgender men will also have an extra swab taken by a clinician as part of routine cervical screening. This is to see if the swab from the vagina is as good as the one from the cervix for finding cells that might lead to cancer. Participants will also take an online survey to measure the acceptability of self-sampling compared to clinician sampling.

This research can inform HPV prevalence and decision-making about HPV screening among transgender people.

A vizsgálat 2 csoportja

  • Trans men and non-binary people with a cervixEgyéb csoport

    Participants will have a clinician-collected cervical screening sample and then collect the following self-samples for research: Vaginal swab, Anal swab, Oral rinse, and Urine sample for the detection of HPV detection.

    Kezelés: HPV DNA methylation assay

  • Trans women and non-binary peopleA vizsgált kezelés

    Participants will collect the following self-samples for research in the clinic: Vaginal swab, Anal swab, Oral rinse, and Urine sample for the detection of HPV detection. Participants will collect the following self-samples for research at home: Vaginal swab, Anal swab, and Oral rinse sample for the detection of HPV detection.

    Kezelés: HPV DNA methylation assay

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
HPV Methylation Self-testing Pilot in Transgender Individuals
Publikációk
A regiszteradat frissítve
2026. február 19.